- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | AstraZeneca's baxdrostat shows promise in phase 3 hypertension study | ||
| Di | AbbVie gains rights to IGI's phase 1 trispecific engager in deal worth over $1.9bn | ||
| Di | Vertex's triple combination cystic fibrosis therapy Alyftrek recommended by NICE | ||
| Mo | Merck to expand respiratory disease portfolio with $10bn Verona Pharma acquisition | ||
| Mo | FDA publishes over 200 complete response letters in effort to increase transparency | ||
| Fr | Amgen's bemarituzumab shows promise in phase 3 gastric cancer study | ||
| Fr | EC approves Biocon Biologics' denosumab biosimilars Vevzuo and Evfraxy | ||
| Fr | Current market challenges are redefining the biotech landscape | ||
| Do | AstraZeneca's Imfinzi regimen approved by EC to treat muscle-invasive bladder cancer | ||
| Do | FDA approves Dizal's oral therapy Zegfrovy to treat advanced lung cancer | ||
| Do | Leveraging AI to supercharge early commercialisation strategy | ||
| 09.07. | Vertex Pharmaceuticals' cystic fibrosis therapy Alyftrek granted EC approval | ||
| 09.07. | Biogen initiates phase 3 study of felzartamab in kidney disease patients | ||
| 09.07. | Sepsis and the impact of antibiotic resistance | ||
| 08.07. | EC approves Jazz Pharmaceuticals' Ziihera for advanced biliary tract cancer | ||
| 08.07. | Moderna shares positive phase 3 results for mRNA flu vaccine candidate | ||
| 08.07. | Cameras on… | ||
| 07.07. | Regeneron's Lynozyfic granted FDA accelerated approval to treat multiple myeloma | ||
| 07.07. | The Considered appoints Tina Bertolini as chief client services officer | ||
| 07.07. | Alzheimer's disease - the silent pandemic and the positive impact of AI | ||
| 04.07. | Communiqué 2025: celebrating excellence in healthcare communications | ||
| 04.07. | UK government publishes 10 Year Health Plan for England to 'reinvent' NHS | ||
| 04.07. | Beyond the badge: communicating the business case for DEI | ||
| 03.07. | AbbVie to expand immunology capabilities with $2.1bn Capstan acquisition | ||
| 03.07. | Avalere Health appoints Saiqa Khan as head of growth |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .